MedPath
HSA Approval

CYBIN INJECTION 100mg/ml

SIN14293P

CYBIN INJECTION 100mg/ml

CYBIN INJECTION 100mg/ml

January 16, 2013

MYLAN PHARMACEUTICALS PTE. LTD.

MYLAN PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMYLAN PHARMACEUTICALS PTE. LTD.
Licence HolderMYLAN PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION, CONCENTRATE

INTRAVENOUS, SUBCUTANEOUS, INTRATHECAL

Medical Information

L01BC01

cytarabine

Manufacturer Information

mylan pharmaceuticals pte. ltd.

Mylan Laboratories Limited [OTL]

Active Ingredients

Cytarabine

100mg/ml

Cytarabine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CYBIN INJECTION 100mg/ml - HSA Approval | MedPath